Mahfouz El Shahawy is the President International Society of cardiovascular Disease Prevention. He was honored by the University of Vienna in Austria with the Golden Doctor Diploma for his achievements in the area of early cardiovascular disease prevention, including more than 100 discoveries, publications, and lectures. He was the lead author for an article titled the ODYSSEY OUTCOMES II Investigators Efficacy and Safety of Alirocumab Versus Ezetimibe over 2 Years (from ODYSSEY COMBO II which was published in the American Journal of Cardiology September 15, 2017. Mahfouz El Shahawy and the Cardiovascular Center of Sarasota was presented with the Top Award for their Scientific Research at the Euro Prevent Conference in April 2017 that was held in Malaga, Spain.
Samer Ellahham has served as Chief Quality Officer at Shaikh Khalifa Medical City since 2009. In his role, he has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Leader, he has focus on ensuring that implementation of this best practices leads to breakthrough improvements in clinical quality and patient safety. He is the recipient of the Quality Leadership Award from the Global Awards for Excellence in Quality and Leadership and the Business Leadership Excellence Award from the World Leadership Congress. He was nominated in 2015 for SafeCare magazine Person of the Year. He is Certified Professional in Healthcare Quality (CPHQ). He is a recognized leader in quality, safety, and the use of robust performance improvement in improving healthcare delivery.
Alexandros Douras is the Ex Chair at Greek Heart Failure Society, and also he is head of the cardiology department in General Hospital of Volos, Greece. He completed his degree in medicine at Hellenic Republic Aristotle University of Thessaloniki, Greece in 1986. Alexandros specialized in the field of cardiology in 1995. He participates in all the activities of the department and great experience in all fields of clinical cardiology and especially in Heart Failure. He has a great experience in Transthoracic (included newer technics of Doppler tissue imaging) and Transesophageal echo. He is interested in Heart Failure - Cardiomyopathies - Congenital HD - Echocardiography. He has Great experience in insertion of temporal pacemakers and in Right Heart Catheterization. He is the member of Hellenic Cardiologic Society (HCS) since 1996 and Chair of Working Group of Heart Failure of HCS, from 2016-2018.
Manuel de Carvalho Rodrigues is the President of the Portuguese Society of Hypertension, Portugal. He was graduated in Medicine from the Faculty of Medical Sciences of the New University of Lisbon and also Specialist in Cardiology by the Order of Physicians. He is Monitor the Chair of Immunology of the New University of Lisbon between 1981 and 1985. And Guest Assistant of the University of Beira Interior - Faculty of Health Sciences, connected to the Cardiocirculatory Block of the 4th year since March 2014. Currently he is President of the Portuguese Society of Hypertension Board in the 2017-2019 biennium
Levan Karazanishvili is currently working as head of the Cardiac Surgery Department at Israel-Georgian Medical Research Clinic HESLICORE Tbilisi, Georgia. From 2002 to 2014 he worked as a cardiac surgeon at CASA DI CURA SAN GAUDENZIO S.P.A. He is worked Faculty of Medicine at University of Turin between 2001 - 2002 and 1995 - 2000 at Bakulev Scientific Center of Cardiovascular Surgery.
Dr. Feiskhanova is currently working as Associate Professor at the Kazan state
medical University. She received her PhD on 2003 from the Kazan state
medical University. Dr. Feiskhanova has authored more than 25 articles in
reputed journals. Her publications reflect her research interests in cardiology,
arrhythmology and rheumatology. She is serving as a member in Association of
cardiologists in Russia. She is currently studying the early cardiac disorders in
patients with rheumatoid arthritis.